Overview
OKB (OKB) and Injective (INJ) sit at different layers of the crypto stack. At current prices ($1,855.02 vs $5.04), market leadership still favors OKB on capitalization, while 24h tape is led by Injective.
Quick winners
Full comparison
| Metric | OKB | INJ |
|---|---|---|
| Price | $1,855.02 | $5.04 |
| Market Cap | $1.81B | $490.41M |
| FDV | — | — |
| Volume 24h | $13.96M | $3.34M |
| Circulating Supply | — | — |
| Total Supply | — | — |
| Max Supply | — | — |
| Rank | 42.00 | 99.00 |
| Dominance | — | — |
| Liquidity | — | — |
| Volatility | +3.50% | +5.78% |
| ATH | — | — |
| ATL | — | — |
| ROI | — | — |
Performance
| Timeframe | OKB | INJ |
|---|---|---|
| 1H | — | — |
| 24H | -0.70% | +2.67% |
| 7D | — | — |
| 30D | — | — |
| 90D | — | — |
| 1Y | — | — |
| YTD | — | — |
| ALL | — | — |
Comparative chart
Technical indicators
| Indicator | OKB | INJ |
|---|---|---|
| RSI | 54.31 | 53.92 |
| MACD histogram | — | — |
| EMA20 | — | — |
| EMA50 | — | — |
| EMA100 | — | — |
| EMA200 | — | — |
| SMA50 | — | — |
| SMA200 | — | — |
| ATR | 66.45 | 0.29 |
| ADX | 20.44 | 12.69 |
| Support | 1,827.82 | 4.91 |
| Resistance | 1,960.30 | 5.47 |
| Trend | bearish | neutral |
| Momentum | 64.00 | — |
| Signal | neutral | neutral |
Automatic technical analysis
Technically, OKB shows RSI 54.31 with trend bias bearish, while Injective sits at RSI 53.92 (neutral). Divergences between momentum and price should be confirmed on higher timeframes.
Fundamentals
| Metric | OKB | INJ |
|---|---|---|
| Consensus | — | — |
| Blockchain | — | — |
| TPS | — | — |
| Block time | — | — |
| Finality | — | — |
| Validators | — | — |
| Staking | — | — |
| TVL | — | — |
| Supply model | — | — |
| Inflation | — | — |
| Developer activity | — | 0.00 |
| Github activity | — | 118.00 |
| On-chain activity | — | — |
| Whale activity | — | — |
| Addresses | — | — |
| Gas fees | — | — |
Ecosystem
OKB
Injective
Pros and cons
Pros of OKB
- OKB often anchors narratives that attract sustained media and analyst coverage.
- OKB typically benefits from deeper liquidity and broader market recognition inside the Top 300 set.
- OKB has an established coin page footprint on PEPS for continuous monitoring.
Cons of OKB
- Indicator stacks on OKB may stay stretched longer than expected in strong trends.
- Data gaps in niche fundamentals still apply — absence of a field is not confirmation.
- Large-cap status for OKB can mean slower percentage upside versus high-beta alternatives.
Pros of Injective
- If technical momentum aligns, Injective may outperform on medium-term windows.
- PEPS tracking for Injective still includes AI score and level context for monitoring.
- Diversifying versus OKB with Injective can change portfolio factor exposure.
- Injective can offer higher relative beta when market attention rotates toward its niche.
Cons of Injective
- Higher volatility on INJ cuts both ways and demands stricter risk limits.
- Incomplete fundamental coverage can hide operational or tokenomic risks.
- Weaker market-cap standing may leave Injective more exposed to liquidity droughts.
Which looks stronger right now?
On the latest snapshot, market-cap leadership belongs to OKB, while short-term performance leans toward Injective. That mix suggests relative strength can flip quickly, so size risk accordingly.
AI summary
Comparing OKB and INJ begins with structure: capitalization, volume and rank. Present prints are $1,855.02 versus $5.04. Momentum and trend can disagree with market-cap hierarchy. That is normal in crypto rotations and should be stress-tested against supports and news flow. Canonical URLs prevent duplicate INJ-vs-OKB pages, keeping SEO equity on one comparison. Keep monitoring winners as data updates.
FAQ
Which is better, OKB or Injective?
“Better” depends on horizon and risk. OKB leads on market cap today, while Injective leads the 24h move — neither is a guarantee.
Which has more upside potential, OKB or INJ?
Higher-beta assets can move more in both directions. Use performance tables and volatility, not headlines, to judge potential ranges.
Which is less risky right now?
Lower volatility and deeper liquidity usually imply milder path risk, but crypto tails remain large for both OKB and Injective.
Which has stronger developer activity?
Check the fundamentals table for developer/github fields when populated. Missing values mean the feed has no reliable reading yet.
Which looks more decentralized?
Decentralization is multi-dimensional (validators, client diversity, token distribution). This page surfaces available consensus/validator fields without over-claiming.
Which has lower fees?
Fee comparisons belong to each network’s fee market. Where gas/fee metrics exist in fundamentals, compare them; otherwise verify on explorers.
Which is better for investing?
Investing choices need personal constraints. Use this comparison as research input, then size positions with an explicit invalidation plan.
Which is better for staking?
If staking fields are present, compare yield mechanics and lockups off-platform. Staking returns are not risk-free.
Which is more used day to day?
Volume, on-chain activity and ecosystem links are practical usage proxies. OKB currently leads traded volume on this snapshot.
Which has the better recent performance?
See the performance table across 1h through 1y. The 24h leader is Injective, but longer windows can disagree.